NASDAQ:AHCO
AdaptHealth Corp. Stock News
$10.98
-0.220 (-1.96%)
At Close: Jun 10, 2024
AHCO vs. BSX: Which Stock Is the Better Value Option?
12:46pm, Friday, 22'nd Mar 2024
Investors looking for stocks in the Medical - Products sector might want to consider either AdaptHealth Corp. (AHCO) or Boston Scientific (BSX). But which of these two stocks is more attractive to val
Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?
10:46am, Friday, 22'nd Mar 2024
Here is how AdaptHealth Corp. (AHCO) and Ascendis Pharma A/S (ASND) have performed compared to their sector so far this year.
3 Small-Cap Leaders Poised for Significant Growth
07:05am, Wednesday, 13'th Mar 2024
They may not be household names like Meta Platforms Inc. NASDAQ: META or investor favorites like Nvidia Corp. NASDAQ: NVDA, but several small stocks, such as Ultra Clean Holdings, Inc. NASDAQ: UCTT, P
AHCO vs. HLN: Which Stock Should Value Investors Buy Now?
12:46pm, Wednesday, 06'th Mar 2024
Investors interested in Medical - Products stocks are likely familiar with AdaptHealth Corp. (AHCO) and Haleon PLC Sponsored ADR (HLN). But which of these two stocks offers value investors a better ba
Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year?
10:45am, Wednesday, 06'th Mar 2024
Here is how AdaptHealth Corp. (AHCO) and Ascendis Pharma A/S (ASND) have performed compared to their sector so far this year.
AdaptHealth Corp. (AHCO) Q4 2023 Earnings Call Transcript
02:15pm, Tuesday, 27'th Feb 2024
AdaptHealth Corp. (AHCO) Q4 2023 Earnings Call Transcript
Why AdaptHealth Stock Is Skyrocketing Today
11:28am, Tuesday, 27'th Feb 2024
AdaptHealth badly missed analysts' consensus earnings estimate for the fourth quarter, but beat their revenue estimate. The earnings miss was due entirely to a goodwill write-down.
AdaptHealth Corp. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
04:05pm, Thursday, 08'th Feb 2024
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions includi
AdaptHealth Corp. to Participate in Upcoming Investor Conference
05:05pm, Tuesday, 19'th Dec 2023
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions includi
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
08:00am, Friday, 10'th Nov 2023
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions includi
AdaptHealth Corp. Announces Third Quarter 2023 Earnings Release Date and Conference Call
04:05pm, Tuesday, 17'th Oct 2023
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions includi
AdaptHealth: Growth Prospects And CEO Appointment Brings Opportunities Amid Legal Matters
09:36pm, Thursday, 14'th Sep 2023
AdaptHealth's partnership with Humana is expected to drive future growth by expanding the customer base and focusing on value-based care. Its diabetes segment is recovering, with growth in Continuous
Why AdaptHealth Stock Dropped Today
07:17pm, Thursday, 17'th Aug 2023
AdaptHealth named Crispin Teufel as its next CEO in June, with an expected start date of Sept. 1. Teufel is now being sued by his former employer, Linde, to prevent him from going to AdaptHealth, to p
AdaptHealth says incoming CEO sued by former employer Linde
07:35am, Thursday, 17'th Aug 2023
U.S. respiratory equipment provider AdaptHealth said on Thursday its incoming CEO Crispin Teufel has been sued by former employer Linde , and is seeking to block the appointment for an unspecified tim
AdaptHealth Corp. (AHCO) Q2 Earnings and Revenues Top Estimates
12:10pm, Tuesday, 08'th Aug 2023
AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.18 per share a year ago.